Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

(2016) Sara Heebøll et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study

(2015) Forouzan Faghihzadeh et al.   BRITISH JOURNAL OF NUTRITION

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

(2015) Shihui Chen et al.   DIGESTIVE AND LIVER DISEASE

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

(2014) Veronique S. Chachay et al.   Clinical Gastroenterology and Hepatology

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

(2014) Miriam Méndez-del Villar et al.   Metabolic Syndrome and Related Disorders

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

(2014) Forouzan Faghihzadeh et al.   NUTRITION RESEARCH

Effects of resveratrol and other polyphenols in hepatic steatosis

(2014) Leixuri Aguirre   WORLD JOURNAL OF GASTROENTEROLOGY

Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

(2014) Kareem Hassan   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity

(2014) Yi Qiao et al.   Food & Function

Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation

(2014) Yu Wang   Diabetes & Metabolism Journal

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

(2013) Silvie Timmers et al.   Annals of the New York Academy of Sciences

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

(2013) Ali Movahed et al.   Evidence-based Complementary and Alternative Medicine

Calorie restriction and sirtuins revisited

(2013) L. Guarente   GENES & DEVELOPMENT

Liver Transplantation for Quality as well as Quantity of Life

(2013) Kamran B Lankarani   Hepatitis Monthly

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

(2013) Alireza Ghaemi et al.   Hepatitis Monthly

Novel insights of dietary polyphenols and obesity

(2013) Shu Wang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds

(2013) Min-Hsiung Pan et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)

(2013) Beth Conlon et al.   Nutrients

Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

(2012) Jun Yoshino et al.   Cell Metabolism

SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function

(2012) Nathan L. Price et al.   Cell Metabolism

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

(2012) Jayesh Kumar Bhatt et al.   NUTRITION RESEARCH

Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism

(2012) Ruben Nogueiras et al.   PHYSIOLOGICAL REVIEWS

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice

(2011) Soyoung Kim et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

(2011) S. Gómez-Zorita et al.   BRITISH JOURNAL OF NUTRITION

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

(2011) Pál Brasnyó et al.   BRITISH JOURNAL OF NUTRITION

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m2

(2011) Hui-Fen Lang et al.   NUTRITION RESEARCH

Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner

(2010) Pamela Fischer-Posovszky et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Regulation of SIRT1 in cellular functions: Role of polyphenols

(2010) Sangwoon Chung et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Resveratrol, sirtuins, and the promise of a DR mimetic

(2010) Joseph A. Baur   MECHANISMS OF AGEING AND DEVELOPMENT

Resveratrol activates energy metabolism by influencing body temperature, locomotor activity and resting metabolic rate in a non-human primate

(2009) Alexandre Dal-Pan et al.   COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Resveratrol alleviates alcoholic fatty liver in mice

(2008) Joanne M. Ajmo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Sirtuins: Novel targets for metabolic disease in drug development

(2008) Wei-jian Jiang   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY

A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice

(2008) Jamie L. Barger et al.   PLoS One